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Purpose/Objective: In prostate cancer RT the delivered dose to 
organs at risk (bladder and rectum) may considerably differ from the 
planned dose distribution, likely impacting the risk of toxicity. 
Computing cumulative DVH during the treatment in IGRT, is crucial 
because it could help to prevent significant changes and would enable 
to generate alarms before a fraction, leading to a new planning re-
computation when required. The aim of this study was to develop a 
model to predict the cumulative bladder DVH from the planned DVH 
using the initial volume of the bladder using multivariate statistics 
tools. 
Materials and Methods: 20 patients, treated for prostate cancer with 
external radiotherapy had one planning CT and weekly CTs. The 
bladder was manually delineated by one expert on all CT scans. The 
actual cumulated dose during treatment was computed using non rigid 
registration from weekly CTs to the planning CT. Hence, cumulated 
bladder DVHs were computed using the propagated weekly doses to 
the baseline anatomy. From the weekly observed anatomical 
modifications, a set of features were extracted. Principal Component 
Analysis (PCA) was used to reduce the DVHs dimension and find 
relationships between planned and cumulative DVHs across the 
population. Then, Partial Least Squares (PLS) methodology was used 
to explain changes in DVHs with respect to the features obtained in 
the previous step. PLS is a methodology which enable to optimally 
relate changes between input and output data. Regressive PLS was 
finally used for training the population model, thereby, optimizing the 
features to predict cumulative DVHs. Thus, 15 patients randomly 
selected were used to train the model, and the 5 remaining patients 
for validation. In the validation, only the initial volume and the initial 
DVH were used as inputs. The cumulated DVHs were estimated with 
the model and compared with the actual computed cumulated DVHs. 
Results: Results suggest that volume, deformation and superficial area 
are the main features related with DVH changes. In the validation, the 
mean error between estimated and cumulated DVH was 0.028 for all 
the bins. Figure 1 shows an exemple of planned, predicted and real 
cumulative DVHs for a given patient as well as the average error per 
dose bin. 
  
Conclusions: Multivariate statistical techniques such as PCA and PLS 
seems to be a useful tool to analyze and to explain changes in DVH 
using anatomic features observed in IGRT. Using this information, we 
obtained a predictive model that provides a good approximation of 
the real cumulated DVHs. The interest relies in that after the training, 
the model uses only a single parameter (initial bladder volume). 
Future work include the estimation of the impact of the generated 
DVHs on toxicity. This work opens the road for adaptive correction by 
the generation of in online alarms when cumulated DVHs go to a 
region of high toxicity risk.  
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Accurate treatment planning and simulation are required to benefit 
from the highly conformal irradiation of tumors in ion radiotherapy. In 
the last years, the application of MRI for treatment planning has 
become more and more important. Thus, the purpose of this study 
was to investigate the potential of MRI for ion radiotherapy treatment 
plan simulation and adaptation in the head region. 
Materials and Methods: We applied a classification-based (Bergé et 
al. 2012) tissue segmentation to derive so-called pseudo CT numbers 
(Johansson et al. 2011) from MR images of three patients with 
cerebral arteriovenous malformations scheduled for ion radiotherapy. 
Several MR imaging sequences (including a 3D ultrashort echotime 
sequence for distinguishing bone tissue from air) were evaluated in 
cross-validation studies. Then, ion radiotherapy treatment plans were 
optimized and simulated using both MRI-based pseudo CT and 
reference CT. Finally, a target shift of 1.6 mm in two directions was 
simulated and a treatment plan adapted to the shift was optimized on 
a corrected CT. The latter consists of a reference CT in which a 
volume around the target was replaced by pseudo CT values. 
Results: The derivation of pseudo CT led to mean absolute errors in 
the range of 141 – 165 HU. Soft tissue was in good agreement with 
reference CT values. Most significant deviations appeared at 
transitions between different tissue classes and at air cavities and 
bones. The former originated from partial volume effects whereas the 
latter resulted from the low SNR of bones in MR imaging, even if the 
UTE sequence was applied. Simulations of ion radiotherapy treatment 
plans using pseudo CT revealed only small underdosages of a target 
volume compared to reference CT simulations. A plan adapted to the 
target volume shift and optimized on the corrected CT exhibited an 
improved target dose coverage compared to a non-adapted plan 
optimized on a reference CT. This result showed that the error 
introduced by replacing a volume of the reference CT containing 
solely soft tissue by pseudo CT values was significantly smaller than 
the error resulting from a target shift of 1.6 mm in two directions. In 
this case, MRI examinations before each fraction would give the 
opportunity of treatment plan adaptation to interfractional changes of 
anatomy or tumor movements without additional dose. 
Conclusions: We demonstrated that an MRI-based derivation of 
pseudo CT values and treatment plan simulation in the head region 
are feasible. In the future, MRI may complement the treatment 
planning process for ion radiotherapy and improve the accuracy so as 
to reap the rewards of highly conformal irradiation of tumors with 
charged particles. Since ions represent a radiation modality being very 
sensitive to inaccuracies in treatment planning, this study is a reliable 
test if MRI-based treatment plan simulation is generally feasible. 
 
 PROFFERED PAPERS: PHYSICS 6: DETECTOR 
DEVELOPEMENTS AND CHARACTERISATION  
  
OC-0246   
Dosimetric characterization of a new commercial plastic 
scintillation detector in FFF MV photon beams 
K. Yenice1, J. Li1 
1Univ. of Chicago Medical Center, Department of Radiation Oncology, 
Chicago, USA  
 
Purpose/Objective: An ideal detector for narrow field dosimetry 
would have good dose and dose rate linearity, energy independence, 
high spatial resolution, tissue equivalence, and orientation 
independence. This study evaluates the characteristics of a new 
commercial plastic scintillation detector in 6 MV and 10 MV high dose 
rate flattening-filter-free (FFF) photon beams from a linear 
accelerator for stereotactic field dosimetry. 
Materials and Methods: A W1 Exradin plastic scintillation detector 
and a Supermax Electrometer from Standard Imaging (Middleton, WI 
USA) were used in FFF beams from a Varian TrueBeam STX machine. 
The scintillation detector has a 1mm by 3mm cylindrical sensitive 
volume coupled to an optical fiber. Dose calibration for the 
scintillator was performed in a special calibration phantom provided 
by the vendor. Resulting calibration factors were stored in the 
electrometer and were used to remove the optic fiber induced 
Cherenkov contamination from the signal using a chromatic 
subtraction algorithm. All in-phantom measurements were carried out 
in a 3D water tank and in-air measurements were performed using a 
custom built brass cap to maintain the electronic equilibrium in the 
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detector volume. Narrow field photon beam data with the W1 
detector were compared to the data measured with other small field 
detectors, including diodes and micro ion chambers. 
Results: The scintillator response remained linear within 0.2% at the 
highest dose rate of 2400 MU/min. Dose rate response of the W1 
detector tracked that of a Famer chamber to within 0.5% when the 
instantaneous dose rate was varied by a factor of five with varying 
detector to source distance. The energy dependence of the 
scintillator response was within the measurement uncertainty of 0.5% 
when the dose in the sensitive region of the detector was referenced 
to that measured by an ADCL calibrated farmer chamber in water. 
Both 6MV and 10MV FFF beam depth dose measurements for 3x3 cm 
and 10x10 cm field sizes with the W1 detector agreed with the 
standard scanning ion chamber data within 0.6% beyond the build-up 
region down to 30 cm depth in water. Total output factors were in 
agreement with the diode and micro ion chamber results within 0.5% 
except at the smallest field of 0.5x0.5 cm, where the discrepancies of 
2-3% were attributed to the non-water equivalence of diode and steel 
central electrode of the ion chamber response. There were no 
significant differences in the scintillator response between the 
parallel and perpendicular orientations to the beam axis except at the 
smallest field sizeof 0.5x0.5cm where the longitudinal size (3mm) of 
the scintillator became comparable to the field size when placed 
perpendicularly to the beam axis. 
Conclusions: The newly available W1 scintillator provides a robust and 
reliable dosimetry system for most challenging small field photon 
beam measurements suitable for accurate stereotactic beam 
commissioning work. 
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Purpose/Objective: In vivo dosimetry is a reliable method to compare 
planned and delivered dose distributions, representing therefore a 
valid tool to systematically verify treatment accuracy and improve 
radiotherapy quality control. In this work, a specific type of MOSFET 
dosimeter called 'MOSkin' was studied to perform in vivo dosimetry in 
high dose rate (HDR) prostate BT. Urethral dose measurements were 
performed with MOSkins, both in single and in dual-MOSkin 
configuration, in a tissue-equivalent phantom reproducing a typical 
prostate BT implant. Obtained data were compared to dose values 
calculated by the Treatment Planning System (TPS). 
Materials and Methods: The design of the MOSkin dosimeter is 
optimized to measure dose in steep dose gradients. Different from 
other commercial MOSFETs, MOSkins are placed within a thin kapton 
layer and hermetically sealed with water-equivalent flexible carrier of 
reproducible thickness. The sensitive volume, defined by the volume 
of the gate oxide, is 4.8 x 10-6 mm3 only. MOSkin detectors have 
shown good characteristics of reproducibility and linearity. 
Experiments performed with the 192Ir source of a HDR brachytherapy 
facility have shown negligible energy response for photons from the Ir-
192 source. Angular response is within the experimental error when 
using the dual-MOSkin configuration. 
In this work, a typical prostate implant with 14 interstitial needles 
and one urethral catheter was realized inside a tissue-equivalent 
cylindrical gel phantom. CT imaging was performed in order to 
precisely localize needles and the urethral catheter and to plan a 
treatment. MOSkin detectors, which were placed in the urethral 
catheter before imaging, were accurately recognized as small 
radiopaque spots. A series of measurements with the same irradiation 
set-up were performed with different dose prescriptions according to 
different developed treatment plans. The cumulative urethral doses 
measured with the single or dual-MOSkin detector were compared to 
the doses calculated by the TPS in the same points. Moreover, the 
contributions to the cumulative dose given by the source moving in 
each single needle were calculated separately and compared to the 
measured ones. 
Results: Comparison of cumulative dose to the urethra measured with 
the single or the dual-MOSkin detectors and the dose calculated by 
the TPS in the same points is reported in Table 1. Measurements were 
repeated for several different treatment plans with different dose 
prescriptions. Results were compared to the dose values calculated by 
the TPS and the highest discrepancies were found to be within 8% and 
3.8% for single and dual-MOSkin detectors, respectively. 
  
Conclusions: MOSkin detectors can be profitably utilized for real-time 
in vivo dosimetry during HDR prostate brachytherapy treatments. The 
dual-MOSkin configuration provides greater accuracy than the single 
MOSkin detector, as angular isotropy is in the first case greatly 
improved. 
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Purpose/Objective: To characterize the newly discovered 
temperature dependence of plastic scintillation detectors (PSDs) 
constructed from BCF-60 and BCF-12 scintillating fibers coupled to 
plastic optical fiber with cyanoacrylate. 
Materials and Methods: PSDs were constructed by optically coupling 2 
mm of scintillating fiber to clear plastic optical fiber with 
cyanoacrylate. Black polyethylene jacketing enclosed the fibers to 
prevent admission of external light. The detectors were calibrated on 
a Cobalt unit using the chromatic removal technique. The detectors 
were immersed in a water bath and irradiated at different 
temperatures ranging from 15 oC to 40 oC, holding all other conditions 
constant. Prior to each irradiation the temperature of the water bath 
was held constant for at least 10 minutes to ensure that the detectors 
and water were in thermal equilibrium. An Andor Luca S CCD camera 
was used to quantify changes in dose measured by the detectors. An 
Andor spectrometer was used to quantify changes in the spectral 
intensity and distribution of different detectors' outputs including a 
detector without scintillating fiber(to isolate temperature effects of 
the production of Cerenkov light by the detector), BCF-60 and BCF-12 
detectors, and a detector with an isolated optical coupling. The latter 
consisted of a BCF-60 detector that was cut two meters below the 
scintillating element and reattached with cyanoacrylate. Only this 
isolated coupling was placed in the water bath while the active 
volume was maintained at room temperature and irradiated to 
produce light. This enabled characterization of the temperature 
dependence of light transmission through a cyanoacrylate coupling. 
Results: BCF-60 and BCF-12 detectors respectively exhibited a 0.50% 
and 0.09% average decrease in measured dose relative to room 
temperature per oC increase in temperature. Results for a pair of BCF-
60 and a pair of BCF-12 detectors are plotted in Figure 1. 
 
Spectrometry demonstrated that the Cerenkov output and the 
transmission of the optical fiber are independent of temperature 
